Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling akt'

Search results for: 'research area pi3k akt signaling akt'

Items 91-100 of 105

Page
per page
  1. 5,7-dihydroxychromone
    N2172 5,7-dihydroxychromone
     1 Citation
    Target: Nrf2/ARE signal|PPAR
    Summary: Nrf2/ARE signal activator and PPARγ agonist
  2. LY3023414
    B6099 LY3023414
    Target: Akt|PI3K|mTOR|DNA-PK
    Summary: class I PI3K isoforms, mTOR and DNA-PK inhibitor
      ≥40.6 mg/mL
  3. JLK 6
    A4403 JLK 6
    Summary: γ-secretase inhibitor
      <22.56 mg/mL
  4. Deltarasin
    A3358 Deltarasin
    Target: Phosphodiesterases (PDEs)
    Summary: KRAS-PDEδ interaction inhibitor
      Soluble in DMSO
  5. NLG919
    A4373 NLG919
     1 Citation
    Summary: Potent IDO pathway inhibitor
      insoluble in H2O; insoluble in EtOH; ≥47.7 mg/mL
  6. Methimazole
    A8472 Methimazole
    Target: ICAM
    Summary: ICAM-1 inhibitor
      ≥49.1 mg/mL
  7. NU 7026
    A8649 NU 7026
    Target: PI3K|DNA-PK|ATM
    Summary: DNPK inhibitor,ATP-competitive and potent
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  8. WYE-125132 (WYE-132)
    B1642 WYE-125132 (WYE-132)
    Target: mTOR
    Summary: ATP-competitive mTOR inhibitor, highly potent
      insoluble in EtOH; insoluble in H2O; ≥13 mg/mL
  9. (-)-Huperzine A
    A1932 (-)-Huperzine A
    Target: NMDA Receptors|AChE
    Summary: NMDA receptor antagonist/AChE inhibitor
      insoluble in H2O; ≥12.12 mg/mL
  10. GDC-0032
    B1047 GDC-0032
    Target: PI3K
    Summary: PI3Kα inhibitor
      ≥23.05 mg/mL

Items 91-100 of 105

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 103item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
Specificity
  1. Selective 56item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Akt 10item
  3. PI3K 21item
  4. Raf 6item
  5. Aurora Kinases 1 item
  6. mTOR 12item
  7. Androgen Receptors 1 item
  8. FLT3 1 item
  9. GSK-3 4item
  10. VEGFR 4item
  11. PDGFR 1 item
  12. Phosphodiesterases (PDEs) 1 item
  13. p38 4item
  14. PKB 1 item
  15. MEK 3item
  16. PORCN 1 item
  17. FGFR 1 item
  18. GABAB Receptors 1 item
  19. NMDA Receptors 1 item
  20. STAT 4item
  21. EGFR 2item
  22. JAK 3item
  23. DNA-PK 3item
  24. HSP90 1 item
  25. Toll-like receptors (TLRs) 1 item
  26. ERK 2item
  27. PKC 5item
  28. ALK 1 item
  29. PKG 1 item
  30. PKA 3item
  31. RSK 1 item
  32. Histamine H1 Receptors 1 item
  33. NO Donors / Precursors 1 item
  34. IL Receptors 1 item
  35. AChE 1 item
  36. BACE 1 item
  37. p70 rsk 1 item
  38. sodium channels 1 item
  39. Smoothened receptor 1 item
  40. Nrf2/ARE signal 1 item
  41. PPAR 1 item
  42. Antibiotic 1 item
  43. Prk 1 item
  44. ICAM 1 item
  45. Rho 1 item
  46. Thrombin Receptor 1 item
  47. prolactin secretion 1 item
  48. gonadotropin release 1 item
  49. TRPC channel 1 item
  50. PKD 1 item
  51. FKBP 1 item
  52. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 15item
  5. Cancer 56item
  6. Cervical Cancer 1 item
  7. Colon Cancer 6item
  8. Colorectal Cancer 6item
  9. Glioblastoma 8item
  10. Glioma 4item
  11. Heart Failure 1 item
  12. Leukemia 6item
  13. Liver Cancer 1 item
  14. Lung Cancer 4item
  15. Lymphoma 2item
  16. Melanoma 5item
  17. Multiple Myeloma 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 4item
  21. Ovarian Cancer 5item
  22. Pancreatic Cancer 6item
  23. Pancreatic Carcinoma 1 item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Renal Cancer 1 item
  27. Rheumatoid Arthritis 2item
  28. Thyroid Cancer 2item
  29. Type 2 Diabetes 1 item